Hypertension is the most important risk factor in the development of stroke. It is also the risk factor most amenable to treatment. The results from 18 controlled trials show a reduction in relative risk of stroke of 25–47% among treated hypertensive patients. This reduction applies both to the elderly and to younger patients, but the absolute reductions are greater among the elderly and the number of patients with hypertension that need to be treated to prevent a stroke is lower in the elderly because they have a higher risk of stroke. The reductions in relative but not absolute risk appear to be similar for both isolated systolic hypertension and combined systolic and diastolic hypertension in the elderly. The case for antihypertensive treatment in the secondary prevention of stroke is less clear but the results of four clinical trials of antihypertensive treatment among patients with and without hypertension and a history of cerebrovascular disease point to a probable benefit The results of the PROGRESS trial will elucidate this further.
WhisnantJP.The decline of stroke. Stroke1984; 15: 160–168.
2.
ReidJL.Hypertension and the brain. Br Med Bull1994; 50: 371–380.
3.
MacMahonSPetoRCutlerJCollinsRSorliePNeatonJBlood pressure, stroke and coronary heart disease. Part 1: Effects of prolonged differences in blood pressure–evidence from nine prospective observational studies corrected for the regression dilution bias. Lancet1990; 335: 765–774.
4.
This article reviewed the association between diastolic blood pressure and stroke from major prospective studies. It showed that lower diastolic blood pressure conferred a lower risk of vascular disease.
5.
MacMahonSNealBRodgersA.Blood pressure lowering for the primary and secondary prevention of coronary and cerebrovascular disease. Schweiz Med Wochenschr1995; 125: 2479–2486.
6.
Overview from 17 studies shows the diastolic blood pressure reduction of 5–6 mmHg reduces stroke risk by 38%. The absolute risk reduction for events was twice as great in the trials in older patients.
7.
CollinsRPetoRMacMahonSHerbertPFiebachNHEberleinKABlood pressure, stroke and coronary heart disease. Part 2: Short-term reductions in blood pressure: overviews of randomised drug trials in their epidemiological context. Lancet1990; 335: 827–838.
8.
AmeryABirkenhagerWBrixkoPBulpittCClementDDeruyttereMMortality and morbidity results from the European Working Party on High Blood pressure in the Elderly Trial. Lancet1985; I: 1348–1354.
9.
This was a large multicentre trial which showed that treatment of systolic and diastolic blood pressure with a diuretic was effective in reducing the relative risk of strokes by 35%.
10.
CoopeJWarrenderTS.Randomised treatment of hypertension in the elderly in primary care. BMJ1986; 293: 1145–1151.
11.
DahlofBLindholmLHHanssonLScherstenBEkhomTWesterPO.Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet1991; 338: 1281–1285.
12.
MRC Working Party. Medical Research Council trial of hypertension in older adults: principal results. BMJ1992; 304: 405–412.
13.
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA1991; 265: 3255–3264.
14.
This trial demonstrated the importance of treating isolated systolic hypertension in the elderly. Diuretics and Beta-blockers were used in the treatment. The trial showed a significant reduction in stroke events.
15.
StaessenJAFagardRThijsLCelisHArabidzeGBirkenhagerWRandomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet1997; 350: 757–764.
16.
This large multicentre trial used a calcium channel antagonist as the therapy for treating isolated systolic hypertension. This showed that treating elderly hypertensive patients reduced the risk of strokes and major cardiovascular events.
17.
MacMahonSRodgersA.The effects of antihypertensive treatment on vascular disease: reappraisal of the evidence in 1994. J Vase Med Biol1993; 4: 265–271.
18.
MacMahonSRodgersANealBChalmersJ.Blood pressure lowering for the secondary prevention of myocardial infarction and stroke. Hypertension1997; 2: 537–538.
19.
An editorial explaining the importance of treating blood pressure in secondary prevention of strokes and myocardial infarction.
20.
IrieKYamaguchiTMinematsuKOmaeT.The J-curve phenomenon in stroke recurrence. Stroke1993; 24: 1844–1849.
21.
RodgersAMacMahonSGambleGSlatteryJSandercockPWarlowC.Blood pressure and risk of stroke in patients with cerebrovascular disease. BMJ1996; 313: 147.
22.
UK-TIA Study Group. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry1991; 54: 1044–1054.
23.
CarterAB.Hypotensive therapy in stroke survivors. Lancet1970; I: 485–489.
24.
Hypertension-Stroke Cooperative Study Group. Effect of antihypertensive treatment on stroke recurrence. JAMA1974; 229: 409–418.
25.
Dutch TIA Trial Study Group. Trial of secondary prevention with atenolol after transient ischaemic attack or non-disabling ischaemic stroke. Stroke1993; 24: 543–548.
26.
ErikssonSOlofssonBOWesterPO, for the TEST study group. Atenolol in secondary prevention after stroke. Cerebrovasc Dis1995; 5: 21–25.
27.
PROGRESS Management Committee. Blood pressure lowering for the secondary prevention of stroke: rationale and design for PROGRESS. J Hypertens1996; 14 (suppl 2): S41–S45.
28.
SandersonS.Hypertension in the elderly: pressure to treat?Health Trends1996; 28: 117–121.
29.
This is a meta-analysis of all published and unpublished randomised control trials of drug treatment in hypertensive elderly patients.
